CD31

CD31

Pack Size Cat No
0.2 mL Concentrate MM068-AA
1.0 mL Concentrate MM068-CC
3.0 mL Predilute MM068-3D
6.0 mL Predilute MM068-6D

Description

CD31, a member of the immunoglobulin superfamily,is a 130-kDa transmembrane glycoprotein also designated as PECAM-1 (platelet endothelial cell adhesion molecule. It is present on the surface of platelets, monocytes, macrophages, and neutrophils and is a constituent of the endothelial intercellular junction. It plays a major role in the adhesion cascade between endothelial cell and the inflammatory cells during inflammation in facilitating leucocyte migration and between endothelial cells during angiogenesis .CD31 is expressed by stem cells of the hematopoietic system and is primarily used to identify and concentrate these cells for experimental studies as well as for bone marrow transplantation. Anti-CD31 has shown to be highly specific and sensitive for vascular endothelial cells. Staining of nonvascular tumors (excluding hematopoietic neoplasms) is rare.

Specifications

Alternative Name PECAM1
Species Mouse
Clone C31.3 + JC/70A
Isotype Mouse IgG
Dilution Range Assay dependent
Species Reactivity Human
Application IHC
Cell Localization Cytoplasm/Membrane
Positive Control Colon carcinoma

DataSheet & SDS

Download Data Sheet
Download SDS Sheet

References

1. Marc P. Pusztaszeri et al, Immunohistochemical Expression of Endothelial Markers CD31, CD34, von Willebrand Factor, and Fli-1 in Normal Human Tissues, Journal of Histochemistry & Cytochemistry , Volume 54(4): 385–395, 2006.

2. Raymond M. Shaheen et al, Antiangiogenic Therapy Targeting the Tyrosine Kinase Receptor for Vascular Endothelial Growth Factor Receptor Inhibits the Growth of Colon Cancer Liver Metastasis and Induces Tumor and Endothelial Cell Apoptosis,  American association of cancer research ,Cancer research ,November 1999.

Request More Information

We would like to get in touch with you for any enquiry related to Pricing/Offer/Product Quotation, Order Support, and Technical Support.

 

Subject *

Name *

Email *

Phone No

Organization

Attach File, if any

Comments